Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
about
Polypoidal choroidal vasculopathy: an update on therapeutic approachesResistance to antivascular endothelial growth factor treatment in age-related macular degenerationProspective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month resultsPolypoidal choroidal vasculopathy: an angiographic discussion.Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients.A prospective study of treatment patterns and 1-year outcome of Asian age-related macular degeneration and polypoidal choroidal vasculopathy.Visual outcomes of vitrectomy for polypoidal choroidal vasculopathy-related breakthrough vitreous haemorrhageThree major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy.Comparison of intravitreal bevacizumab to photodynamic therapy for polypoidal choroidal vasculopathy: short-term resultsGenetic and functional dissection of ARMS2 in age-related macular degeneration and polypoidal choroidal vasculopathy.Idiopathic polypoidal choroidal vasculopathy in a young man: case report and literature review.Choroidal thickness outside the laser irradiation area after photodynamic therapy in polypoidal choroidal vasculopathy.Time-lag between subretinal fluid and pigment epithelial detachment reduction after polypoidal choroidal vasculopathy treatmentOutcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome.Pattern of presentation of idiopathic polypoidal choroidal vasculopathy in Ibadan, Sub-Saharan Africa.1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathyPhotodynamic therapy versus anti-vascular endothelial growth factor agents for polypoidal choroidal vasculopathy: a meta-analysisSeasonal variations of acute massive submacular haemorrhage associated with age-related macular degeneration.Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy.Intravitreal bevacizumab and ranibizumab injections for patients with polypoidal choroidal vasculopathyPhotodynamic therapy: current role in the treatment of chorioretinal conditionsPolypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiographyShort-term effectiveness of intravitreal bevacizumab vs. ranibizumab injections for patients with polypoidal choroidal vasculopathyResults of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathyPolypoidal choroidal vasculopathy in Korean patients with large submacular hemorrhage.The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathyIntravitreal Anti-vascular Endothelial Growth Factor for Treating Polypoidal Choroidal Vasculopathy with Grape-like Polyp Clusters.Long-term outcome of intravitreal ranibizumab treatment, compared with photodynamic therapy, in patients with polypoidal choroidal vasculopathy.Comparison of the 1-year Outcomes of Conbercept Therapy between Two Different Angiographic Subtypes of Polypoidal Choroidal Vasculopathy.Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab responseOne-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.Reduced-fluence photodynamic therapy and anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy in an Indian populationOne-year results of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy.Evaluation of verteporfin pharmakokinetics--redefining the need of photosensitizers in ophthalmology.Photodynamic therapy combined with intravitreal injection of vascular endothelial growth factor antibody for polypoidal choroidal vasculopathy.Characteristics of fine vascular network pattern associated with recurrence of polypoidal choroidal vasculopathy.Comparison of initial treatment between 3-monthly intravitreal aflibercept monotherapy and combined photodynamic therapy with single intravitreal aflibercept for polypoidal choroidal vasculopathy.Five-year results of photodynamic therapy with verteporfin for Japanese patients with neovascular age-related macular degeneration.Asian age-related macular degeneration phenotyping study: rationale, design and protocol of a prospective cohort study.Incidence, outcomes, and risk factors for hemorrhagic complications in eyes with polypoidal choroidal vasculopathy following photodynamic therapy in Indian subjects.
P2860
Q27006758-18717A91-D08A-48A3-97EF-BE4B37CDE9CDQ27015781-F2D63CC4-7E85-4B2F-8655-E54D37BB4BB7Q27311334-BA40272D-39D8-476A-B235-5476E6CEB290Q33523990-79A7AA2C-C2EB-45F2-A6EA-55E48A4EDB51Q33650784-CC22589A-5526-41D6-A969-808990C3945CQ33825750-A16854E8-7214-43B1-B8B9-8AC8608D5781Q33891162-36CD8E52-F4C4-40A3-BEFE-F2329C68D3ECQ33982669-57F98C9E-70C5-4756-9497-356D3B43873BQ34007126-F78B5821-BA92-418A-85C0-F62FD6AC7A09Q34551648-1F7896B3-91F5-4137-A31A-EC4908DC6AE1Q34570373-D821F9A6-3CE6-4AB9-8101-0E2E067072D4Q34585510-B0890B22-521D-4C11-A5B5-CA43F490AC18Q34695085-C9F57079-4CB1-42EE-B716-C6499FA6506BQ34718477-4A9F953F-378F-4C3B-A532-FE7CA72F0914Q34844667-A65719E2-5D1D-46D6-A35C-98F109B8EF84Q35677770-61E73D3F-2358-45EA-82EF-D96E666E0A8BQ35713167-15C81ABF-EBFB-4148-A4FA-6836951FC35DQ35762576-2F346026-6EFB-411B-86C9-99A5FBC6A67EQ35762763-DE03ECA7-1201-484C-9752-63BF95F6274DQ35820349-4BBE07FC-64EE-47D0-8F1D-85D1051A87A6Q35888341-0D250525-49D2-44A9-89D4-BBCC99180441Q35954073-5707B131-3235-44F6-9669-3F6A07675919Q35999201-7BA1307D-7E34-4E6D-8F30-FCFF816915D9Q36786002-0FCFCEFF-FE06-4D0F-A70F-CCF5DF0C9B8CQ37065541-7ACCBD5B-2B7D-4067-A12C-209A2A59E2BCQ37070218-C347627F-A298-4AC3-9881-621594AEAE9BQ37136866-6ADCFE5C-7689-4C79-AF54-10C4C9643734Q37168836-ABB364BF-0ACF-4EDB-8C3B-6745E099F857Q37445392-37F97881-40A1-4B57-882D-1E8795D705EEQ37552779-5ABDC540-BB74-4714-A1D0-CB4D74612DE6Q37554103-E3024768-3E60-4907-BC24-F4C371CA7C21Q37661641-23017B1A-C1F4-4ED6-A54F-6FD201FFE06DQ37901282-1B486B3A-C063-46D5-B0AE-58E539F0E8A1Q38023892-370B7719-AA83-490D-AE01-8F6AA2D9B771Q38477676-AF4E0D3A-61ED-449C-93C6-1164E59CBE33Q38543259-B0AC776E-A008-44D0-BD12-65CB079169C3Q38930149-B3A60006-CA7C-4F1E-9E6F-0586C8E0B03DQ39568542-D410E37C-69FD-4E12-876B-BF976367C463Q40019102-0472CC48-63AA-4C57-ACAE-AD3C8113420FQ41102960-46F3A2AD-8D8D-49AB-B9B2-DB249C03DB88
P2860
Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Photodynamic therapy with vert ...... of a prospective case series.
@ast
Photodynamic therapy with vert ...... of a prospective case series.
@en
type
label
Photodynamic therapy with vert ...... of a prospective case series.
@ast
Photodynamic therapy with vert ...... of a prospective case series.
@en
prefLabel
Photodynamic therapy with vert ...... of a prospective case series.
@ast
Photodynamic therapy with vert ...... of a prospective case series.
@en
P2093
P50
P1433
P1476
Photodynamic therapy with vert ...... s of a prospective case series
@en
P2093
David T L Liu
Tak-Hung Wong
Wai-Man Chan
P304
P356
10.1016/J.OPHTHA.2003.12.056
P577
2004-08-01T00:00:00Z